Company intelligence / Profile preview

Gatik

Irvine, California, USAgatik.ai ↗

Ownership: Private
Development stage: Commercial

Overview

GATC Health has validated its MAT platform with high sensitivity/specificity predictions, enabling rapid identification of safe/effective compounds. Its lead non-opioid candidate for opioid use disorder has shown safety and efficacy in preclinical models and will enter clinical trials imminently. The MAT system reduces animal testing, shortens timelines, and increases success rates compared to traditional methods.

Therapeutic areas: PsychiatryEndocrinologyNeurology
Modalities: Small molecule
Industry: Biotech

Partnerships

Lisata TherapeuticsMedical and Commercial International/Lloyd's of London syndicate

Beyond the preview

Go deeper on Gatik.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gatik.

Explore the full profile